Emelia J. Benjamin MD, ScM

Associate Provost for Faculty Development, BUMC & Jay and Louise Coffman Professor,

Professor, Cardiovascular Medicine

73 Mt Wayte Ave | (617) 638-8968
Emelia Benjamin
Sections

Cardiovascular Medicine

Centers

Whitaker Cardiovascular Institute

Framingham Heart Study

Evans Center for Interdisciplinary Biomedical Research

Biography

Emelia J. Benjamin, MD, ScM, FACC, FAHA, received her AB at Harvard, her MD at Case Western Reserve University, and her Epidemiology ScM at Harvard School of Public Health. She is a Professor of Medicine and Epidemiology at Boston University and is a cardiologist at Boston Medical Center. She is a Robert Dawson Evans Distinguished Professor of Medicine at Chobanian and Avedisian School of Medicine.

She is author of over 800 peer-reviewed publications that focus on the genetics, epidemiology, and prognosis of a variety of cardiovascular conditions and markers including atrial fibrillation, vascular function, and systemic inflammation. She has been continuously NIH funded since 1998, and currently is multi-Principal Investigator on an R01 atrial fibrillation grant [2R01HL092577], several chronic pain grants, and is the Training Director on the Boston University American Heart Association Strategically Focused Research Network on Cardio-Oncology. She is an internationally recognized expert on the epidemiology of atrial fibrillation. Dr. Benjamin has Co-Chaired the NIH National Heart Lung and Blood Institutes’ (NHLBI) Atrial Fibrillation Working Group, which advised the NHLBI’s atrial fibrillation research agenda, and resulted in 6 publications.

Dr. Benjamin has conducted research at the Framingham Study since 1988. She is a Member of the Executive Committee, and is Co-Director of the Medical Endpoints Committee. She was Principal Investigator of the grant that recruited the second generation of the Framingham Study's ethnic/racial minority cohort, the Omni Study.

In addition to her research, she is the inaugural Associate Provost for Faculty Development for Boston University Medical Campus, and the inaugural Vice Chair for Faculty Development and Diversity, BU Department of Medicine. She co-designed and co-leads Faculty Development Programs for Early, Mid-Career, Under-Represented Ethnic and Racial, Women, and Clinical Leaders. In 2023 she completed the Columbia University Advanced Coaching Certification.

A passionate and dedicated mentor, she has won local and national awards for mentoring, education, and research. She was inducted into the Association of American Physicians and she won the 2020 Alliance for Academic Internal Medicine Diversity, Equity, and Inclusion Award.

An active volunteer for the American Heart Association since 1992, she has served on a variety of local and national Committees. She is Past-Chair of the American Heart Association’s Functional Genomics and Translational Biology Council and Study Section, and the annual Heart and Stroke Statistical Update. She received the 2015 Paul Dudley White Award, the 2016 AHA Gold Heart Award, the 2016 Population Research Prize, the 2019 Laennec Clinician/ Educator Lecturer, and the Genomics and Precision Medicine 2019 Distinguished Achievement Award, and the 2022 Distinguished Scientist Award.

Other Positions

Education

MD, Case Western Reserve University

ScM, Harvard School of Public Health

Publications

Published on 5/5/2025

Sibley S, Bedford J, Wetterslev M, Johnston B, Garside T, Kanji S, Whitehouse T, Welters I, Ostermann M, Balik M, Lancini D, Dharmaraj B, Benjamin EJ, Walkey AJ, Cuthbertson BH. Atrial fibrillation in critical illness: state of the art. Intensive Care Med. 2025 May 05. PMID: 40323451.

Published on 4/7/2025

Yao Z, Tasdighi E, Dardari ZA, Jha KK, Osuji N, Rajan T, Boakye E, Rodriguez CJ, Matsushita K, Simonsick EM, Lima JAC, Widome R, Cohen DL, Appel LJ, Khera A, Hall ME, Judd S, Cole SA, Vasan RS, Benjamin EJ, Bhatnagar A, DeFilippis AP, Blaha MJ. Correction to: Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration-Tobacco Working Group. Circulation. 2025 Apr 08; 151(14):e922. PMID: 40193538.

Published on 4/5/2025

Song JJ, Stafford RA, Pohlmann JE, Kim ISY, Cheekati M, Dennison S, Brush B, Chatzidakis S, Huang Q, Smirnakis SM, Gilmore EJ, Mohammed S, Abdalkader M, Benjamin EJ, Dupuis J, Greer DM, Ong CJ. Later midline shift is associated with better post-hospitalization discharge status after large middle cerebral artery stroke. Sci Rep. 2025 Apr 05; 15(1):11738. PMID: 40188256.

Published on 3/19/2025

Erhabor J, Yao Z, Tasdighi E, Shahawy OE, Benjamin EJ, Bhatnagar A, Blaha MJ. Association of e-cigarette use, psychological distress, and substance use: Insights from the All of Us Research Program. Addict Behav. 2025 Jul; 166:108322. PMID: 40112576.

Published on 3/18/2025

Yao Z, Tasdighi E, Dardari ZA, Jha KK, Osuji N, Rajan T, Boakye E, Rodriguez CJ, Matsushita K, Simonsick EM, Lima JAC, Widome R, Cohen DL, Appel LJ, Khera A, Hall ME, Judd SE, Cole SA, Vasan RS, Benjamin EJ, Lotufo PA, Benseñor IM, El Khoudary SR, Barinas-Mitchell E, Janssen I, Psaty BM, Eaton CB, LaMonte MJ, Cawthon PM, Orwoll ES, Irvin MR, Bhatnagar A, DeFilippis AP, El-Shahaway O, Blaha MJ. Association Between Cigarette Smoking and Subclinical Markers of Cardiovascular Harm. J Am Coll Cardiol. 2025 Mar 18; 85(10):1018-1034. PMID: 40074467.

Published on 3/15/2025

Erhabor J, Yao Z, Tasdighi E, Benjamin EJ, Bhatnagar A, Blaha MJ. E-cigarette Use and Incident Cardiometabolic Conditions in the All of Us Research Program. Nicotine Tob Res. 2025 Mar 15. PMID: 40089810.

Published on 3/6/2025

Choi SH, Jurgens SJ, Xiao L, Hill MC, Haggerty CM, Sveinbjörnsson G, Morrill VN, Marston NA, Weng LC, Pirruccello JP, Arnar DO, Gudbjartsson DF, Mantineo H, von Falkenhausen AS, Natale A, Tveit A, Geelhoed B, Roselli C, Van Wagoner DR, Darbar D, Haase D, Soliman EZ, Davogustto GE, Jun G, Calkins H, Anderson JL, Brody JA, Halford JL, Barnard J, Hokanson JE, Smith JD, Bis JC, Young K, Johnson LSB, Risch L, Gula LJ, Kwee LC, Chaffin MD, Kühne M, Preuss M, Gupta N, Nafissi NA, Smith NL, Nilsson PM, van der Harst P, Wells QS, Judy RL, Schnabel RB, Johnson R, Smit RAJ, Gabriel S, Knight S, Furukawa T, Blackwell TW, Nauffal V, Wang X, Min YI, Yoneda ZT, Laksman ZWM, Bezzina CR, Alonso A, Psaty BM, Albert CM, Arking DE, Roden DM, Chasman DI, Rader DJ, Conen D, McManus DD, Fatkin D, Benjamin EJ, Boerwinkle E, Marcus GM, Christophersen IE, Smith JG, Roberts JD, Raffield LM, Shoemaker MB, Cho MH, Cutler MJ, Rienstra M, Chung MK, S Olesen M, Sinner MF, Sotoodehnia N, Kirchhof P, Loos RJF, Nazarian S, Mohanty S, Damrauer SM, Kaab S, Heckbert SR, Redline S, Shah SH, Tanaka T, Ebana Y, Holm H, Stefansson K, Ruff CT, Sabatine MS, Lunetta KL, Lubitz SA, Ellinor PT. Sequencing in over 50,000 cases identifies coding and structural variation underlying atrial fibrillation risk. Nat Genet. 2025 Mar; 57(3):548-562. PMID: 40050430.

Published on 3/6/2025

Roselli C, Surakka I, Olesen MS, Sveinbjornsson G, Marston NA, Choi SH, Holm H, Chaffin M, Gudbjartsson D, Hill MC, Aegisdottir H, Albert CM, Alonso A, Anderson CD, Arking DE, Arnar DO, Barnard J, Benjamin EJ, Braunwald E, Brumpton B, Campbell A, Chami N, Chasman DI, Cho K, Choi EK, Christophersen IE, Chung MK, Conen D, Crijns HJ, Cutler MJ, Czuba T, Damrauer SM, Dichgans M, Dörr M, Dudink E, Duong T, Erikstrup C, Esko T, Fatkin D, Faul JD, Ferreira M, Freitag DF, Ganesh SK, Gaziano JM, Geelhoed B, Ghouse J, Gieger C, Giulianini F, Graham SE, Gudnason V, Guo X, Haggerty C, Hayward C, Heckbert SR, Hveem K, Ito K, Johnson R, Jukema JW, Jurgens SJ, Kääb S, Kane JP, Kany S, Kardia SLR, Kavousi M, Khurshid S, Kamanu FK, Kirchhof P, Kleber ME, Knight S, Komuro I, Krieger JE, Launer LJ, Li D, Lin H, Lin HJ, Loos RJF, Lotta L, Lubitz SA, Lunetta KL, Macfarlane PW, Magnusson PKE, Malik R, Mantineo H, Marcus GM, März W, McManus DD, Melander O, Melloni GEM, Meyre PB, Miyazawa K, Mohanty S, Monfort LM, Müller-Nurasyid M, Nafissi NA, Natale A, Nazarian S, Ostrowski SR, Pak HN, Pang S, Pedersen OB, Pedersen NL, Pereira AC, Pirruccello JP, Preuss M, Psaty BM, Pullinger CR, Rader DJ, Rämö JT, Ridker PM, Rienstra M, Risch L, Roden DM, Rotter JI, Sabatine MS, Schunkert H, Shah SH, Shim J, Shoemaker MB, Simonson B, Sinner MF, Smit RAJ, Smith JA, Smith NL, Smith JG, Soliman EZ, Sørensen E, Sotoodehnia N, Strbian D, Stricker BH, Teder-Laving M, Sun YV, Thériault S, Thorolfsdottir RB, Thorsteinsdottir U, Tveit A, van der Harst P, van Meurs J, Wang B, Weiss S, Wells QS, Weng LC, Wilson PW, Xiao L, Yang PS, Yao J, Yoneda ZT, Zeller T, Zeng L, Zhao W, Zhou X, Zöllner S, Ruff CT, Bundgaard H, Willer C, Stefansson K, Ellinor PT. Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases. Nat Genet. 2025 Mar; 57(3):539-547. PMID: 40050429.

Published on 2/22/2025

Jaiswal V, Ang SP, Kumar D, Deb N, Jaiswal A, Joshi A, Nasir YM, Bandyopadhyay D, Michos ED, Benjamin EJ, Fonarow GC. Sodium-Glucose Cotransporter-2 Inhibitors and Arrhythmias: A Meta-Analysis of 38 Randomized Controlled Trials. JACC Adv. 2025 Mar; 4(3):101615. PMID: 39985887.

Published on 2/22/2025

Siegel NA, Zhao J, Benjamin EJ, Bhatnagar A, Hall JL, Stokes AC. Identifying Patterns of Tobacco Use and Associated Cardiovascular Disease Risk Through Machine Learning Analysis of Urine Biomarkers. JACC Adv. 2025 Mar; 4(3):101630. PMID: 39985885.

View full list of 939 publications.